Financial Data
LIVN Financial Data
Revenue · Earnings · Margins · Balance Sheet · Cash Flow
LIVNLivaNova PLC
Healthcare / Medical - Devices
Leader
Strong Relative Position
Latest quote
- Momentum83
- Value60
- Quality64
- Risk resilience71
- Sentiment—
Latest Quarter at a Glance
Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.
Quarterly Financial Statements
Updated Nov 19, 2026.
LIVN, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.
| Metric | Trend | YoY | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | +9.9% | $393M | $391M | $362M | $361M | $358M | $353M | $317M | $322M | |
| Gross profit | +8.2% | $265M | $274M | $245M | $240M | $245M | $239M | $221M | $219M | |
| Operating income | −47.4% | $28M | $50M | $52M | $43M | $54M | $54M | $49M | $37M | |
| Net income | +28.0% | $34M | $109M | $22M | $31M | $27M | $27M | −$327M | $56M | |
| EPS (diluted) | +22.4% | $0.60 | $1.93 | $0.40 | $0.57 | $0.49 | $0.50 | −$6.01 | $1.02 | |
| Gross margin | −1.0 pts | 67.4% | 70.1% | 67.6% | 66.4% | 68.4% | 67.8% | 69.7% | 68.2% | |
| Operating margin | −7.9 pts | 7.2% | 12.7% | 14.4% | 11.8% | 15.1% | 15.4% | 15.3% | 11.5% | |
| Net margin | +1.2 pts | 8.7% | 27.8% | 6.2% | 8.6% | 7.5% | 7.7% | -103.3% | 17.4% |
| Metric | Trend | YoY | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −13.5% | $74M | $67M | $15M | $82M | $85M | $63M | $24M | $79M | |
| Capital expenditure | −34.6% | −$31M | −$32M | −$14M | −$32M | −$23M | −$15M | −$11M | −$10M | |
| Free cash flow | −31.2% | $43M | $35M | $926K | $50M | $62M | $48M | $13M | $68M | |
| Free cash flow margin | −6.5 pts | 10.9% | 9.0% | 0.3% | 13.9% | 17.4% | 13.6% | 4.2% | 21.2% |
| Metric | Trend | YoY | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | +6.1% | $2.71B | $2.64B | $2.52B | $2.61B | $2.56B | $2.51B | $2.56B | $2.51B | |
| Total liabilities | −4.2% | $1.34B | $1.32B | $1.30B | $1.41B | $1.40B | $1.38B | $1.52B | $1.19B | |
| Shareholders' equity | +18.6% | $1.37B | $1.33B | $1.21B | $1.20B | $1.16B | $1.12B | $1.03B | $1.32B | |
| Total debt | −28.5% | $348M | $352M | $335M | $473M | $487M | $483M | $678M | $677M | |
| Cash and equivalents | −12.8% | $564M | $517M | $540M | $636M | $646M | $594M | $738M | $429M |
| Metric | Trend | YoY | Sep '26 | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio | 26.68 | 23.33 | 34.57 | — | — | — | — | 36.07 | ||
| P/B ratio | +1.39 | 3.81 | 3.32 | 3.06 | 3.19 | 2.42 | 2.31 | 2.29 | 1.73 | |
| Return on equity | +33.1 pts | 14.3% | 14.2% | 8.8% | -20.2% | -18.8% | -18.8% | -21.5% | 4.8% | |
| Debt to equity | −0.17 | 0.25 | 0.27 | 0.28 | 0.39 | 0.42 | 0.43 | 0.66 | 0.51 | |
| Free cash flow yield | −4.4 pts | 2.5% | 3.4% | 4.3% | 4.5% | 6.8% | 6.3% | 6.1% | 6.0% |
Current Stock Metrics
Current fundamental, technical, and risk readings in one place.
| Metric | Value |
|---|---|
| P/E ratio | 25.68x |
| P/B ratio | 3.69x |
| Revenue growth (YoY) | 9.87% |
| EPS growth (YoY) | 26.53% |
| Gross margin | 67.91% |
| Operating margin | 11.46% |
| ROE | 15.35% |
| ROIC | 8.74% |
| Debt to equity | 0.25 |
| FCF yield | 2.55% |
As of Nov 18, 2026
| Metric | Value |
|---|---|
| Close As of Nov 18, 2026 | $94.54 |
| Volume As of Nov 13, 2026 | 742,278 |
| RSI (14) As of Nov 13, 2026 | 65.47 |
| MACD As of Nov 13, 2026 | 3.55 |
| MACD signal As of Nov 13, 2026 | 2.82 |
| MACD histogram As of Nov 13, 2026 | 0.72 |
| ADX (14) As of Nov 13, 2026 | 30.8 |
| SMA (50) As of Nov 13, 2026 | $80.32 |
| SMA (200) As of Nov 13, 2026 | $74.18 |
| ATR (14) As of Nov 13, 2026 | $3.32 |
| Historical volatility (annualized) As of Nov 13, 2026 | 69.17% |
| Volume (20-day average) As of Nov 13, 2026 | 762,455 |
| Metric | Value |
|---|---|
| Resilience score | 71/100 |
| Beta | 1.09 |
| Annual volatility | 39.16% |
| Max drawdown | -18.89% |
| Sharpe ratio | 1.38 |
| VaR (95%, 1-day) | -2.93% |
As of Nov 18, 2026
Detailed Metrics
Additional measures remain available here while the decision pages stay focused.
No additional fundamental metrics are available.
No additional technical indicators are available.
No additional risk measures are available.
Related Links
LIVN Financial Data FAQ
What is LivaNova PLC's revenue?
LivaNova PLC's revenue is one of the core financial data points for LIVN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.
Is LivaNova PLC's revenue growing?
Revenue growth shows whether LivaNova PLC is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.
What is LIVN's EPS?
LIVN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.
What is LivaNova PLC's net income?
LivaNova PLC's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.
How much free cash flow does LivaNova PLC generate?
Free cash flow shows how much cash LivaNova PLC generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.
How much cash and debt does LivaNova PLC have?
Cash and debt help frame LIVN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.